Pharmaceuticals
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.
This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 10.
Red Cross Faulted Over Blood Supply
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The FDA said it has found widespread and persistent problems with the storage and distribution of blood supplies by the American Red Cross.
Source: WSJ.com: Health - November 13, 2009 Category: Pharmaceuticals Tags: PAID Source Type: news
Swine Flu Sickens 22 Million AmericansEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
An estimated 22 million Americans have been sickened with swine flu since April and 3,900 have died, as vaccine shipments fell behind government predictions.
Source: WSJ.com: Health - November 13, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Abortion Upends Health-Bill AllianceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The last thing Democrats need right now is a fight over health care with a powerful group that ought to be an ally, yet that's what may be taking shape with the nation's Catholic bishops.
Source: WSJ.com: Health - November 13, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Health-Bill Disclosure Rule Is ResistedEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Health legislation moving through Congress would force drug makers to disclose how much they spend on continuing medical education classes for doctors, sparking some resistance from the industry.
Source: WSJ.com: Health - November 13, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Sen. Reid Weighs Rise in Medicare TaxEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Senate Majority Leader Harry Reid is considering a proposal to raise Medicare payroll taxes on couples who make more than $250,000 a year.
Source: WSJ.com: Health - November 13, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Nycomed reports continued satisfactory performance in the third quarter 2009Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
, with total net turnover increasing by 0.9% (3.2% in local currencies) to €820.0 million. Pantoprazole sales were resilient after losing patent protection in May in 12 European countries. On a regional basis, sales in most emerging markets exhibited strong growth. The pipeline portfolio advanced significantly.
Source: World Pharma News - November 13, 2009 Category: Pharmaceuticals Source Type: news
Abbott to Acquire Novel Investigational Biologic to Treat Chronic PainEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Abbott (NYSE: ABT) announced a definitive agreement to acquire the global rights to PanGenetics BV's PG110 fully humanized antibody to Nerve Growth Factor (NGF), expanding the company's pain care portfolio and leveraging its expertise in biologics. PG110 is a novel biologic in Phase I clinical trial development that targets NGF for the treatment of chronic pain.
Source: World Pharma News - November 13, 2009 Category: Pharmaceuticals Source Type: news
Repros Appoints Dr. Jaye Thompson to Board of DirectorsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Nola E. Masterson Appointed As Board Chair
THE WOODLANDS, Texas--(HSMN NewsFeed)--Repros Therapeutics Inc. (NasdaqGM:RPRX ) today announced that it has elected Dr. Jaye Thompson to its Board of Directors, and as a member of the Boards Audit Committee, ... Biopharmaceuticals, PersonnelRepros Therapeutics
Source: HSMN NewsFeed - November 12, 2009 Category: Pharmaceuticals Source Type: news
New Web Sites Educate About Triglycerides and HDL CholesterolEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ABBOTT PARK, Ill., Nov. 12 /PRNewswire-FirstCall/ -- Nearly one
in three adult Americans have triglyceride (trig) levels that are
above normal and nearly 34 million have low HDL "good" cholesterol
levels. To help increase awareness about the...
Source: Drugs.com - Pharma News - November 12, 2009 Category: Pharmaceuticals Source Type: news
Lexicon Announces Positive Phase 2 Results of LX1031 in Non-Constipating Irritable Bowel SyndromeEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
-LX1031 demonstrates beneficial effect of new mechanism of
action - Clinical response correlates with reduction in biomarker
of serotonin synthesis - Favorable safety profile observed in
patients treated during four-week study Conference Call on...
Source: Drugs.com - Clinical Trials - November 12, 2009 Category: Pharmaceuticals Source Type: clinical trials
Pharmacyclics Announces Poster Presentations and Clinical Update at the 51st Annual Meeting of the American Society of HematologyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SUNNYVALE, Calif., Nov. 12 /PRNewswire-FirstCall/ --
Pharmacyclics, Inc. (NASDAQ:PCYC)
today announced that posters related to PCI-24781 and PCI-32765
have been selected for presentation at the 51st Annual Meeting of
the American Society of...
Source: Drugs.com - Clinical Trials - November 12, 2009 Category: Pharmaceuticals Source Type: clinical trials
Holllis-Eden to Present Interim Data From Its Phase I/II Clinical Studies of Apoptone (HE3235) at Molecular Targets and Cancer Therapeutics ConferenceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
- Company Provides Update on Progress of Lead Compounds
-
SAN DIEGO, Nov. 12 /PRNewswire-FirstCall/ -- Hollis-Eden
Pharmaceuticals, Inc. (NASDAQ:HEPH)
, will present results of its ongoing human clinical Phase I/II
open-label dose-ranging...
Source: Drugs.com - Clinical Trials - November 12, 2009 Category: Pharmaceuticals Source Type: clinical trials
Vision-Sciences, Inc. Announces $6.2 Million in Revenue for the First Half of Fiscal 2010Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ORANGEBURG, N.Y., Nov. 12, 2009 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc., (Nasdaq:VSCI) today announced results for its second quarter and first half of fiscal 2010, ended September 30, 2009. For the second quarter of fiscal 2010, revenues were $2.9 million, an increase of $0.1 million, or 4%, over the second quarter of fiscal 2009, ended September 30, 2008. For the first half of fiscal 2010, revenues were $6.2 million, an increase of $0.7 million, or 13%, over the first half of fiscal 2009. Loss from operations in the second quarter of fiscal 2010 was $3.1 million compared to $3.7 million in the second quarter of fiscal ...
Source: Medical News (via PRIMEZONE) - November 12, 2009 Category: Pharmaceuticals Source Type: news
GM's Marketing CzarEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Vice Chairman Bob Lutz pitted his Cadillac against all comers and got the best of them.
Source: Forbes.com Healthcare News - November 12, 2009 Category: Pharmaceuticals Source Type: news
Sharps Compliance Corp. Announces Filing of Registration Statement for Public Offering of Common StockEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
HOUSTON, Nov. 12, 2009 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (Nasdaq:SMED) ("Sharps" or the "Company"), a leading full-service provider of cost-effective disposal solutions for medical waste and unused dispensed medications generated outside the hospital and large healthcare facility setting, announced today that is has filed a registration statement on Form S-3 with the Securities and Exchange Commission relating to the public offering of 3,220,000 shares of its common stock, of which 500,000 shares will be sold by the Company and 2,720,000 shares will be sold by certain of its stockholders. The Company and the sell...
Source: Medical News (via PRIMEZONE) - November 12, 2009 Category: Pharmaceuticals Source Type: news
Democrats Herald Report on Health CostsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Democrats Thursday said a report from the Business Roundtable on health-care costs showed their legislative efforts would reduce employers' costs in coming years.
Source: WSJ.com: Health - November 12, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Good Medicine: When to Say No to Your DoctorEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
How much of the $2.5 trillion we spend on health care goes down the drain for tests and treatments that don't help, run up the bill and may even cause harm?
Source: Forbes.com Healthcare News - November 12, 2009 Category: Pharmaceuticals Source Type: news
Trading Outlook for BioElectronics Corporation Issued by StockPreacher.comEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
DALLAS, Nov. 12, 2009 (GLOBE NEWSWIRE) -- StockPreacher.com announces an investment report featuring BioElectronics Corporation (Pink Sheets:BIEL). The report includes financial and investment analysis, analyst consensus, and pertinent industry information you need to know to make an educated investment decision.
Source: Medical News (via PRIMEZONE) - November 12, 2009 Category: Pharmaceuticals Source Type: news
ev3 Inc. to Present at the 2009 Citi Investment Research Small and Mid Cap Conference on November 19, 2009Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
PLYMOUTH, Minn., Nov. 12, 2009 (GLOBE NEWSWIRE) -- ev3 Inc. (Nasdaq:EVVV) today announced that Julie Tracy, senior vice president and chief communications officer, is scheduled to present at the 2009 Citi Investment Research Small/Mid Cap Conference at 11:20 a.m. Eastern Time on Thursday, November 19, 2009 at the Citigroup Global Markets Offices located at 388 Greenwich Street, Mezzanine Level, New York, New York.
Source: Medical News (via PRIMEZONE) - November 12, 2009 Category: Pharmaceuticals Source Type: news
OccuLogix, dba TearLab Corporation, Reports Q3-09 Financial ResultsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SAN DIEGO, Nov. 12, 2009 (GLOBE NEWSWIRE) -- OccuLogix, Inc., dba TearLab Corporation (TearLab) (Nasdaq:TEAR) (TSX:TLB) today reported its consolidated financial results for the quarter ended September 30, 2009. All dollar amounts are expressed in U.S. currency, and results are reported in accordance with United States generally accepted accounting principles.
Source: Medical News (via PRIMEZONE) - November 12, 2009 Category: Pharmaceuticals Source Type: news
Vision-Sciences, Inc. Does Not Satisfy Nasdaq's Requirement to Maintain a Majority of Independent DirectorsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ORANGEBURG, N.Y., Nov. 12, 2009 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc., (Nasdaq:VSCI) notified The Nasdaq Stock Market on November 9, 2009 that it does not meet the Nasdaq requirement that its Board of Directors consist of at least a majority of independent members. The noncompliance resulted from Mr. Warren Bielke being appointed as Interim Chief Executive Officer of the Company, and thereby no longer being an "independent" director, following the resignation of Mr. Ron Hadani as President, Chief Executive Officer and Director.
Source: Medical News (via PRIMEZONE) - November 12, 2009 Category: Pharmaceuticals Source Type: news
OXiGENE to Present at American Society of Hematology and AACR/NCI/EORTC MeetingsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SOUTH SAN FRANCISCO, Calif., Nov. 12, 2009 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN) (Stockholm:OXGN), a clinical stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that data from preclinical studies of its vascular disrupting agent (VDA) drug candidate OXi4503 will be presented at the upcoming meeting of the American Society of Hematology in New Orleans, LA, December 5-8, 2009.
Source: Medical News (via PRIMEZONE) - November 12, 2009 Category: Pharmaceuticals Source Type: news
Indian medical devices cos finding space in global arenaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A bunch of mid-sized Indian companies have seized the opportunity in the global life-saving medical devices market.
Source: The Economic Times Healthcare and Biotech News - November 12, 2009 Category: Pharmaceuticals Source Type: news
BioAlliance Pharma Presents Results for Its New Oral Chemotherapy Nanoparticle Innovation at the AAPS Annual Meeting in Los Angeles, November 8 to 12, 2009Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
PARIS--(BUSINESS WIRE)--Nov 12, 2009 - Regulatory News:
BioAlliance Pharma SA (Euronext Paris: BIO), a company dedicated
to the treatment and supportive care of cancer and AIDS patients,
has presented its results on new oral chemotherapy...
Source: Drugs.com - Clinical Trials - November 12, 2009 Category: Pharmaceuticals Source Type: clinical trials
Medicare Payroll Tax May Fund ReformEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Senate Democrats are weighing increasing Medicare payroll taxes on wealthy Americans to plug a financing gap in a health-overhaul bill, people familiar with discussions said.
Source: WSJ.com: Health - November 12, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Momenta Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual Healthcare ConferenceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
CAMBRIDGE, Mass., Nov. 12, 2009 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that Richard P. Shea, Chief Financial Officer, will deliver a corporate presentation at the Lazard Capital Markets 6th Annual Healthcare Conference on Wednesday, November 18th at 10:30 am EST. The conference will be held at The Saint Regis New York in New York City.
Source: Medical News (via PRIMEZONE) - November 12, 2009 Category: Pharmaceuticals Source Type: news
Action on Antipsychotic Drugs and DementiaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
LONDON, November 12, 2009 - An action plan to
tackle the over prescribing of antipsychotic drugs to dementia
sufferers was announced by the Government today in response to the
findings of an independent review by Professor Sube Banerjee,
Head...
Source: Drugs.com - Pharma News - November 12, 2009 Category: Pharmaceuticals Source Type: news
Despite Some Benefit, Drug Ads Can Be Harmful to Your HealthEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
As Congress revisits drug ad regulation, researchers make
recommendations for minimizing harm and maximizing benefits of drug
ads
WASHINGTON, Nov. 12, 2009-While the debate over prescription
drug advertising persists, a new study released online in...
Source: Drugs.com - Pharma News - November 12, 2009 Category: Pharmaceuticals Source Type: news
Asian growth boosts sales at SynergyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Strong demand for the decontamination of hospital equipment in Asia and Europe has buoyed revenues at Synergy Healthcare, the health services company.
Source: FT.com - Drugs and Healthcare - November 12, 2009 Category: Pharmaceuticals Source Type: news
DePuy plans to phase out manufacture at Leeds facility(Nov 12, 2009)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
November 12, 2009 - Following a detailed review of its global production requirements versus capacity, DePuy intends to phase out manufacturing at its facility in St. Anthony’s Road, Beeston, Leeds, subject to statutory consultation. The company plans to rationalise its product portfolio to focus on lines that best meet the current and emerging needs of surgeons and patients. Several of these product lines are produced at the Leeds facility. .....
Source: Johnson and Johnson - November 12, 2009 Category: Pharmaceuticals Source Type: organizations
Stemedica President Invited To Lecture At The University Of OxfordEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Nikolai Tankovich, MD, Ph.D., President and Chief Medical Officer of Stemedica Cell Technologies, Inc. was invited to lecture at a multi-disciplinary seminar at the Centre for Science and Society at Trinity College, a constituent college of the University of Oxford, England. The seminar, which focused on current research and medical applications for stem cells, was attended by more than 300 professors and staff representing all facets of the University. (PRWeb Nov 12, 2009)
Read the full story at http://www.prweb.com/releases/stemedica-presents/oxford-stem-cell-trials/prweb3196604.htm
Source: PRWeb: Medical Pharmaceuticals - November 12, 2009 Category: Pharmaceuticals Source Type: news
The New Pollutants Brewing in Our WaterEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Report Discusses Emergence of Endocrine Disruptors in Potomac (PRWeb Nov 12, 2009)
Read the full story at http://www.prweb.com/releases/Potomac_Conservancy/River_Report/prweb3189304.htm
Source: PRWeb: Medical Pharmaceuticals - November 12, 2009 Category: Pharmaceuticals Source Type: news
NeoVista, Inc. Announces First Neovascular AMD Patient Treated with VIDION® ANV® Therapy System in Europe Following CommercializationEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Ophthalmic Clinic in Pisa, Italy is First in Europe to Treat Neovascular AMD Patients with New Epimacular Brachytherapy System (PRWeb Nov 12, 2009)
Read the full story at http://www.prweb.com/releases/2009/11/prweb3192374.htm
Source: PRWeb: Medical Pharmaceuticals - November 12, 2009 Category: Pharmaceuticals Source Type: news
US Drug Watchdog Offers Urgent New Information To Denture Cream Users Of Super Poligrip and Fixodent About Zinc PoisoningEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The US Drug Watchdog is ramping up its urgent nationwide denture cream alert for any US consumer using the denture creams Super Poligrip, or Fixodent, because of the potential severe side affects, due to possible zinc poisoning. The group is saying," exposure to excess zinc can lead to unexplained weakness, numbness, loss of sensation or other nerve symptoms. Super Poligrip, or Fixodent denture cream users who experience these symptoms should call the US Drug Watchdog Immediately at 866-714-6466." The US Drug Watchdog is saying, "one out of ten US citizens use denture creams. If anyone has had these side eff...
Source: PRWeb: Medical Pharmaceuticals - November 12, 2009 Category: Pharmaceuticals Source Type: news
GoIndustry DoveBid Has Been Awarded 'Corporate Supplier Excellence Award' By Procter & GambleEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Procter & Gamble Company (NYSE: PG) hosted its annual supplier awards event on Tuesday 3rd November recognizing the company's top performing suppliers.
Source: Pharmaceutical Online News - November 12, 2009 Category: Pharmaceuticals Source Type: news
First Patients Complete Treatment at ProCure Proton Therapy Center in Oklahoma CityEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
OKLAHOMA CITY--(HSMN NewsFeed)--The first group of patients have completed treatment at the ProCure Proton Therapy Center in Oklahoma City, the sixth center in the country to provide proton therapy, an alternative to X-ray radiation that spares healthy tis... Devices, OncologyProCure Treatment Centers, Proton Therapy, proton beam, radiotherapy
Source: HSMN NewsFeed - November 12, 2009 Category: Pharmaceuticals Source Type: news
Abbott to Acquire Novel Investigational Biologic to Treat Chronic PainEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Anti-NGF Compound Adds to Company's Early-Stage Pain Care Pipeline
ABBOTT PARK, Ill., Nov. 12 (HSMN NewsFeed) -- Abbott (NYSE: ABT ) announced today a definitive agreement to acquire the global rights to PanGenetics BV's PG110 fully humanized antibody... Biopharmaceuticals, AcquisitionsAbbott, PanGenetics, Nerve Growth Factor
Source: HSMN NewsFeed - November 12, 2009 Category: Pharmaceuticals Source Type: news
Abbott To Acquire Novel Investigational Biologic To Treat Chronic PainEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Abbott (NYSE: ABT) announced today a definitive agreement to acquire the global rights to PanGenetics BV's PG110 fully humanized antibody to Nerve Growth Factor (NGF), expanding the company's pain care portfolio and leveraging its expertise in biologics.
Source: Pharmaceutical Online News - November 12, 2009 Category: Pharmaceuticals Source Type: news
Researchers from UC Irvine Medical Center Find Clinical Advantages to Using RapidArc(R) Radiotherapy for the Stereotactic Treatment of TumorsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
RapidArc treatments are faster and potentially expose patients to less overall radiation during treatment
PALO ALTO, Calif., Nov. 12 (HSMN NewsFeed) -- Researchers from the University of California, Irvine Medical Center reported last week that image-... Devices, OncologyVarian Medical Systems, RapidArc, radiotherapy, VMAT
Source: HSMN NewsFeed - November 12, 2009 Category: Pharmaceuticals Source Type: news
3M Health Care and Zargis Medical Awarded "Innovation of the Year" for Littmann(R) Model 3200 Stethoscope with Cardioscan SoftwareEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Stethoscope with Bluetooth(R) Technology Recognized by Popular Science as Revolutionary Innovation
ST. PAUL, Minn. & STAMFORD, Conn.--(HSMN NewsFeed)--3M Health Care and Zargis Medical, a majority-owned subsidiary of Speedus Corp. (Nasdaq:SPDE ), announ... Devices3M Health Care, Zargis Medical, Littmann, Cardioscan, Electronic Stethoscope
Source: HSMN NewsFeed - November 12, 2009 Category: Pharmaceuticals Source Type: news
Mirna Therapeutics Appoints Dr. Paul Lammers as President and CEOEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
AUSTIN, Texas--(HSMN NewsFeed)--Mirna Therapeutics (Mirna), a spin-off of Asuragen, Inc. announced today that Paul Lammers, M.D. has joined the Company as its President, Chief Executive Officer and a member of the Board of Directors. As President and CEO... Biopharmaceuticals, PersonnelMirna Therapeutics, microRNA
Source: HSMN NewsFeed - November 12, 2009 Category: Pharmaceuticals Source Type: news
Elekta's Election CommitteeEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
STOCKHOLM, Sweden--(HSMN NewsFeed)--In accordance with the decision at the Annual General Meeting on September 15, 2009, Elektas (STO:EKTAB) Chairman of the Board has contacted the companys largest shareholders to form an Election Committee. Subsequently... Devices, Oncology, PersonnelElekta, radiosurgery, radiotherapy
Source: HSMN NewsFeed - November 12, 2009 Category: Pharmaceuticals Source Type: news
EnWave Corporation: EnWave Signs Letter of Intent to Sell nutraREV(R) Food Dehydration Technology in South and Central AmericaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
VANCOUVER, BRITISH COLUMBIA (MARKET WIRE) EnWave Corporation (TSX VENTURE: ENW)(FRANKFURT: E4U) ("EnWave" or "the Company"), has signed a Letter of Intent ("LOI") with a North American consortium for the purpose of selling up to four commercial-scale nutraREV(R) food dehydration machines over the next four years. The machines will be used for the production of a variety of dried fruit and vegetable products grown in South and Central America. SmartPac, LLC of California, and Innovative Food Systems ("IFS") of Princeton, British Columbia (together, "the Consortium"), intend to establish the first nutraREV(R) plant in Central America
Source: Market Wire - Pharmaceuticals and Biotech - November 12, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare ENW E4U Source Type: news
Ondine Biopharma Corporation: Ondine Biopharma Announces Third Quarter 2009 Financial ResultsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
VANCOUVER, BRITISH COLUMBIA (MARKET WIRE) Ondine Biopharma Corporation (the "Company" or "Ondine") (TSX: OBP)(AIM: OBP) a medical device company developing photodisinfection based products, today announced its financial results for the third quarter ended September 30, 2009.
Source: Market Wire - Pharmaceuticals and Biotech - November 12, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech OBP Source Type: news
Shire Reports Findings From an Analysis Examining Emotional Lability in Children With ADHD Taking Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CIIEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Post hoc analysis of Phase 3 study data presented at national
psychiatric meeting
PHILADELPHIA, Nov. 12 /PRNewswire-FirstCall/ -- Shire plc , the
global specialty biopharmaceutical company, announced findings from
a post hoc analysis examining...
Source: Drugs.com - Clinical Trials - November 12, 2009 Category: Pharmaceuticals Source Type: clinical trials
Abbott to Acquire Novel Investigational Biologic to Treat Chronic PainEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Anti-NGF Compound Adds to Company's Early-Stage Pain Care
Pipeline
ABBOTT PARK, Ill., Nov. 12 /PRNewswire-FirstCall/ -- Abbott
(NYSE:ABT) announced today a definitive
agreement to acquire the global rights to PanGenetics BV's PG110
fully humanized...
Source: Drugs.com - Pharma News - November 12, 2009 Category: Pharmaceuticals Source Type: news
United-Guardian Reports 20% Earnings IncreaseEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
HAUPPAUGE, N.Y., Nov. 12, 2009 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (Nasdaq:UG) reported today that earnings reached a record level for the first nine months of 2009, increasing 20% over last year to $2,992,420 ($0.60 per share) from $2,487,057 ($0.50 per share) in the same period in 2008. Earnings for the 3 months ended September 30, 2009 increased 22% to $1,081,748 ($0.22 per share) from $911,494 ($0.18 per share) in the third quarter of 2008. Net sales for the 9-month period were up 8% compared with last year, primarily due to an increase in sales of the company's medical lubricant products, which increased by 41%....
Source: Medical News (via PRIMEZONE) - November 12, 2009 Category: Pharmaceuticals Source Type: news
SGR Repair Bill Failure Could Cool Physician Support for Healthcare ReformEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Organized medicine is anticipating a vote on a bill that would rewrite Medicare's controversial sustainable growth rate formula for physician reimbursement, which would avert a 21.2% pay cut for 2010. Medscape Medical News
Source: Medscape Business of Medicine Headlines - November 12, 2009 Category: Pharmaceuticals Source Type: info
